Global Street Food: la cocina de la calle
Diseño interior January 1, 2009 DOI: 10.1176/appi.ajp.2019.19010035 (opens in new tab) via OpenAlex
Study at a glance
AI-extracted from the abstract| Characteristics | Review Randomized Peer reviewed |
|---|---|
| Keywords | Geography |
| Citations | 632 |
| Key findings | The database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders, but continued research is warranted. |
Abstract
Randomized clinical trials support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression and cancer-related anxiety. The research to support the use of LSD and ayahuasca in the treatment of psychiatric disorders is preliminary, although promising. Overall, the database is insufficient for FDA approval of any psychedelic compound for routine clinical use in psychiatric disorders at this time, but continued research on the efficacy of psychedelics for the treatment of psychiatric disorders is warranted.